Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial.

Authors :: Wei AH
Döhner H
Sayar H
Ravandi F
Montesinos P
Dombret H
Selleslag D
Porkka K
Jang JH
Skikne B
Beach CL
Prebet T
Zhang G
Risueño A
Ugidos M
See WL
Menezes D
Roboz GJ
Source :: American journal of hematology [Am J Hematol] 2023 Apr; Vol. 98 (4), pp. E84-E87. Date of Electronic Publication: 2023 Feb 06.
Publication Year :: 2023

Subjects :: Humans
Antimetabolites, Antineoplastic therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Azacitidine therapeutic use
Leukemia, Myeloid, Acute drug therapy

Full Text Access

Tools